Base Operating Expenses. “Base Operating Expenses” means the total of Operating Expenses paid by Landlord during calendar year 2008 (the “Base Expense Year”), as adjusted under § 4.5 below.
Appears in 3 contracts
Sources: Sublease (Transcept Pharmaceuticals Inc), Sublease (Transcept Pharmaceuticals Inc), Office Lease (Novacea Inc)
Base Operating Expenses. “Base Operating Expenses” means the total of Operating Expenses paid by Landlord during calendar year 2008 2018 (the “Base Expense Year”), as adjusted under § 4.5 below.
Appears in 3 contracts
Sources: Office Lease (ESSA Pharma Inc.), Office Lease (Satsuma Pharmaceuticals, Inc.), Office Lease (Satsuma Pharmaceuticals, Inc.)
Base Operating Expenses. “Base Operating Expenses” means the total of Operating Expenses paid by Landlord during calendar year 2008 2004 (the “Base Expense Year”), as adjusted under § 4.5 4.6 below.
Appears in 3 contracts
Sources: Commercial Sublease Agreement (Sunesis Pharmaceuticals Inc), Commercial Sublease Agreement (Sunesis Pharmaceuticals Inc), Office Lease (Sirf Technology Holdings Inc)
Base Operating Expenses. “Base Operating Expenses” means the total of Operating Expenses paid by Landlord during calendar year 2008 2014 (the “Base Expense Year”), as adjusted under § 4.5 below.
Appears in 2 contracts
Sources: Office Lease (Loxo Oncology, Inc.), Office Lease (Sunesis Pharmaceuticals Inc)
Base Operating Expenses. “Base Operating Expenses” means the total of Operating Expenses paid by Landlord during calendar year 2008 2005 (the “Base Expense Year”), as adjusted under § 4.5 below.
Appears in 1 contract
Sources: Office Lease (Envivio Inc)
Base Operating Expenses. “Base Operating Expenses” means the total of Operating Expenses paid by Landlord during calendar year 2008 2020 (the “Base Expense Year”), as adjusted under § 4.5 below.
Appears in 1 contract
Sources: Office Lease (Day One Biopharmaceuticals Holding Co LLC)